CRISPR Technology: Exploring the Promise & Challenges of Genome EditingIN MY OPINIONBenjamin Borgo, Head of Portfolio Management for Genome Engineering and Modulation, MilliporeSigmaLAST WORD301208Danie du Plessis, Executive VP Medical Affairs, Kyowa Kirin [TYO: 4151]Immunotherapy: Shaping a New Era of Patient Centric CareCOVER STORYAVANCE BIOSCIENCESLEADING THE WAY IN GLP/GMP-COMPLIANT ASSAY DEVELOPMENTXUENING HUANG, CEO
< Page 3 | Page 5 >